SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-083568
Filing Date
2024-04-01
Accepted
2024-04-01 17:04:32
Documents
21
Period of Report
2024-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d801492d8k.htm   iXBRL 8-K 57192
2 EX-3.1 d801492dex31.htm EX-3.1 68490
3 EX-4.1 d801492dex41.htm EX-4.1 95227
4 EX-4.2 d801492dex42.htm EX-4.2 98513
5 EX-4.3 d801492dex43.htm EX-4.3 79971
6 EX-10.1 d801492dex101.htm EX-10.1 204908
7 EX-10.2 d801492dex102.htm EX-10.2 147238
8 EX-10.3 d801492dex103.htm EX-10.3 147762
9 EX-10.4 d801492dex104.htm EX-10.4 83954
  Complete submission text file 0001193125-24-083568.txt   1384509

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240327.xsd EX-101.SCH 2840
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240327_lab.xml EX-101.LAB 17979
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240327_pre.xml EX-101.PRE 11251
25 EXTRACTED XBRL INSTANCE DOCUMENT d801492d8k_htm.xml XML 3740
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 24810694
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)